Regeneron· @Regeneron · X·· 1 小时前精选AI 评分60
AI 导读
再生元宣布其针对成人进行性骨化性纤维发育不良（FOP）的疗法在III期临床试验中取得84周阳性结果。相关数据在#ASBMR2026上公布，更多结果可通过链接查看。
推荐理由
再生元公布其FOP疗法III期试验84周阳性结果，读者可了解该罕见病在研疗法的长期数据进展。
正文
Today we announced positive 84-week results from a Phase 3 clinical trial investigating our therapy in adults with fibrodysplasia ossificans progressiva (FOP). Learn more about our findings at #ASBMR2026: https://bit.ly/4yN8RJN
来源：Regeneron · x.com